|
|
 |
Vaccine
Information Statements
VISs by vaccine
Hepatitis
B
VIS [PDF]
Published
July 18, 2007
Translations: Up-to-date
You are encouraged
to distribute the up-to-date English-language VIS (above) at the same time
as the translation.
Translations: Out-of-date
The translations for
some VISs on our website are from previously published English-language
versions that have since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued. Please ensure that your
patients receive information consistent with the current English-language
version of
the following VISs.
|
 |
|
|
|
|
Translations
of the July 11, 2001, English VIS
These translations do not contain the
following CDC updates:
- On July 18, the CDC posted an
interim VIS for hepatitis B. There are minor changes throughout, but
the main purpose of the update is to emphasize the birth dose for
all children.
- A final version will be developed.
Translations
of the December 16, 1998, English VIS
These translations do not
contain the following CDC updates:
- The number of new infections
occurring annually is listed as 80,000 (previously 200,000).
- "Sharing of needles" when
injecting illegal drugs has been added as a way of spreading the
virus.
- The targeted groups to
be vaccinated has been expanded to include public safety workers
who might be exposed to infected blood or body fluids, household
contacts
of persons with chronic HBV infection, and hemodialysis patients.
- A time frame "in 6
months" has been added to the risk factor "people who have
more than one sex partner."
- Information about the two-dose
adolescent vaccine series has been added.
- The statement "Serious
allergic reactions are extremely rare with any vaccine" has been
added.
- The website of Vaccine
Adverse Event Reporting System has been added.
- A new URL for the National
Vaccine Injury Compensation Program is listed.
This page was updated on July 18, 2007
|
|
|
|
|
|
|
|
| Immunization Action Coalition 1573 Selby Avenue Saint Paul, MN 55104 |
|
| tel 651-647-9009 fax 651-647-9131 |
|
| email admin@immunize.org |
|